{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:56:05Z","timestamp":1791024965909,"version":"4.1.0"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejpb.2026.115243","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:11:12Z","timestamp":1790547072000},"page":"115243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumor-responsive hyalo-chitosan nanoparticles for targeted delivery of andrographolide in CD44+ breast cancer cells"],"prefix":"10.1016","volume":"228","author":[{"given":"Sohaila A.","family":"Shoala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidy","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"Elbedaiwy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marium M.","family":"Shamaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal A.","family":"Elsheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115243_b0005","article-title":"Cancer control in Egypt: investing in health","author":"Alorabi","year":"2021","journal-title":"ASCO Post"},{"key":"10.1016\/j.ejpb.2026.115243_b0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: Global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115243_b0015","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s12553-021-00592-0","article-title":"Classification of breast cancer types, sub-types and grade from histopathological images using deep learning technique","volume":"11","author":"Zewdie","year":"2021","journal-title":"Heal. Technol."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115243_b0020","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036905","article-title":"Breast cancer: a review of risk factors and diagnosis","volume":"103","author":"Obeagu","year":"2024","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-023-00517-2","article-title":"Predicting breast cancer types on and beyond molecular level in a multi-modal fashion","volume":"9","author":"Zhang","year":"2023","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.ejpb.2026.115243_b0030","volume":"9s2:","author":"Nounou","year":"2015"},{"key":"10.1016\/j.ejpb.2026.115243_b0035","doi-asserted-by":"crossref","DOI":"10.20517\/cdr.2020.113","article-title":"DNA direct reversal repair and alkylating agent drug resistance","author":"Gutierrez","year":"2021","journal-title":"Cancer Drug Resistance"},{"issue":"19","key":"10.1016\/j.ejpb.2026.115243_b0040","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.3390\/molecules27196229","article-title":"Folic Acid Antimetabolites (Antifolates): a Brief Review on Synthetic strategies and Application Opportunities","volume":"27","author":"Kovalev","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115243_b0045","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00280-015-2903-8","article-title":"Antimitotic drugs in the treatment of cancer","volume":"76","author":"Van Vuuren","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejpb.2026.115243_b0050","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/s41401-023-01093-8","article-title":"Chemotherapy-induced metastasis: molecular mechanisms and clinical therapies","volume":"44","author":"Su","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0055","article-title":"Chemotherapy\u2013types, side effects and resistance","volume":"3","author":"Ismail","year":"2020","journal-title":"Journal of Tomography System and Sensor Application"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0060","doi-asserted-by":"crossref","DOI":"10.5530\/pres.14.2.15","article-title":"Traditional and herbal medicines: opportunities and challenges","volume":"14","author":"Saggar","year":"2022","journal-title":"Pharmacognosy Research"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13684","article-title":"Recent advance of herbal medicines in cancer- a molecular approach","volume":"9","author":"Ali","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ejpb.2026.115243_b0070","article-title":"Andrographolide, a natural anti-inflammatory agent: an Update","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/chromsci\/bmaa091","article-title":"Andrographolide: a Review of Analytical Methods","volume":"59","author":"Patil","year":"2021","journal-title":"J. Chromatogr. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115243_b0080","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7150\/ijbs.7723","article-title":"Andrographolide Suppress Tumor Growth by Inhibiting TLR4\/NF-\u03baB Signaling Activation in Insulinoma","volume":"10","author":"Zhang","year":"2014","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-018-0926-9","article-title":"Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway","volume":"37","author":"Peng","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4103\/wjtcm.wjtcm_50_21","article-title":"Andrographolide protects retinal ganglion cells in rats with glaucoma by regulating the bcl-2\/bax\/caspase-3 signaling pathway","volume":"8","author":"Li","year":"2022","journal-title":"World Journal of Traditional Chinese Medicine"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0095","first-page":"234","article-title":"ADDITIVE CYTOTOXIC EFFECT OF CISPLATIN AND ANDROGRAPHIS PANICULATA EXTRACT THROUGH THE MODULATION OF APOPTOTIC MARKERS, CYCLIN-D AND VEGF EXPRESSIONS IN SKOV3 OVARIAN CANCER CELL LINE","volume":"17","author":"Wanandi, i.,","year":"2025","journal-title":"Int J App Pharm"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115243_b0100","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3390\/plants12061220","article-title":"Evaluations of Andrographolide-Rich Fractions of Andrographis paniculata with Enhanced potential Antioxidant, Anticancer, Antihypertensive, and Anti-Inflammatory Activities","volume":"12","author":"Adiguna","year":"2023","journal-title":"Plants"},{"key":"10.1016\/j.ejpb.2026.115243_b0105","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1007\/s11095-012-0964-5","article-title":"Engineered andrographolide nanoparticles mitigate paracetamol hepatotoxicity in mice","volume":"30","author":"Roy","year":"2013","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115243_b0115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1742-7843.2009.00498.x","article-title":"Predicting drug disposition via application of a biopharmaceutics drug disposition classification system","volume":"106","author":"Benet","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115243_b0120","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1002\/jps.22693","article-title":"Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P\u2010glycoprotein","volume":"100","author":"Ye","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"22","key":"10.1016\/j.ejpb.2026.115243_b0125","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.3390\/nano12224073","article-title":"Improved activity of Herbal Medicines through Nanotechnology","volume":"12","author":"Dewi","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejpb.2026.115243_b0130","article-title":"Exploring nanoformulation drug delivery of herbal actives for enhanced therapeutic efficacy","author":"Sharma","year":"2024","journal-title":"A Comprehensive Review. Intelligent Pharmacy"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0135","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s13346-022-01230-6","article-title":"Development of andrographolide-loaded solid lipid nanoparticles for lymphatic targeting: Formulation, optimization, characterization, in vitro, and in vivo evaluation","volume":"13","author":"Shrivastava","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115243_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.639409","article-title":"Encapsulation of Andrographolide in poly(lactide-co-glycolide) Nanoparticles: Formulation Optimization and in vitro Efficacy Studies","volume":"9","author":"Oseni","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115243_b0145","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3390\/ph17070966","article-title":"Enhancement of Cognitive Function by Andrographolide-Loaded Lactose \u03b2-Cyclodextrin Nanoparticles: Synthesis, Optimization, and Behavioural Assessment","volume":"17","author":"Paramanick","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"60","key":"10.1016\/j.ejpb.2026.115243_b0150","doi-asserted-by":"crossref","first-page":"34726","DOI":"10.1039\/C8RA04156C","article-title":"Andrographolide-loaded silk fibroin nanoparticles","volume":"8","author":"Zhongyu","year":"2018","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/ijnpnd.ijnpnd_85_23","article-title":"Synthesis and characterization of andrographolide: Albumin nanoparticles and their anticancer activity in HeLa cancer cell line","volume":"14","author":"Lavanya","year":"2024","journal-title":"International Journal of Nutrition, Pharmacology, Neurological Diseases"},{"key":"10.1016\/j.ejpb.2026.115243_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124993","article-title":"Preparation and characterization of andrographolide nano-cocrystals using hummer acoustic resonance technology","volume":"668","author":"Qu","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115243_b0165","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/pharmaceutics13081290","article-title":"Optimization of Production Parameters for Andrographolide-Loaded Nanoemulsion Preparation by Microfluidization and evaluations of its Bioactivities in Skin Cancer Cells and UVB Radiation-Exposed Skin","volume":"13","author":"Asasutjarit","year":"2021","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115243_b0170","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Research in Pharmaceutical Sciences"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115243_b0175","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/pharmaceutics14030614","article-title":"Challenges and Complications of Poly(lactic-co-glycolic acid)-based Long-Acting Drug Product Development","volume":"14","author":"Lim","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.34172\/apb.2020.022","article-title":"Cyclodextrin based Nanoparticles for Drug delivery and Theranostics","volume":"10","author":"Gadade","year":"2020","journal-title":"Advanced Pharmaceutical Bulletin"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0185","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/10717544.2020.1736208","article-title":"Fibroin nanoparticles: a promising drug delivery system","volume":"27","author":"Pham","year":"2020","journal-title":"Drug Deliv."},{"issue":"23","key":"10.1016\/j.ejpb.2026.115243_b0190","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.3390\/molecules27238596","article-title":"Challenges in Preparation of Albumin Nanoparticle-based Radiopharmaceuticals","volume":"27","author":"Ballinger","year":"2022","journal-title":"Molecules"},{"issue":"14","key":"10.1016\/j.ejpb.2026.115243_b0195","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.3390\/molecules26144185","article-title":"Challenges and Progress in Nonsteroidal Anti-Inflammatory Drugs Co-Crystal Development","volume":"26","author":"Nugrahani","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.115243_b0200","article-title":"Recent insights into Nanoemulsions: their preparation, properties and applications","volume":"18","author":"Mushtaq","year":"2023","journal-title":"Food Chem.: X"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115243_b0205","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/pharmaceutics14051003","article-title":"Novel luteolin-loaded chitosan decorated nanoparticles for brain-targeting delivery in a sporadic Alzheimer\u2019s disease mouse model: Focus on antioxidant, anti-inflammatory, and amyloidogenic pathways","volume":"14","author":"Abbas","year":"2022","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115243_b0210","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202270020","article-title":"Hyaluronic\u2010Acid\u2010Coated Chitosan Nanoparticles for Insulin Oral delivery: Fabrication, Characterization, and Hypoglycemic Ability","volume":"22","author":"Wu","year":"2022","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejpb.2026.115243_b0215","article-title":"Advances and challenges in the use of chitosan and its derivatives in biomedical fields: a review","volume":"5","author":"Yadav","year":"2023","journal-title":"Carbohydr. Polym. Technol. Appl."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115243_b0220","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3390\/pharmaceutics13101686","article-title":"Chitosan nanoparticles at the biological interface: implications for drug delivery","volume":"13","author":"Aibani","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0225","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-021-02025-4","article-title":"Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment","volume":"21","author":"Sharifi-Rad","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejpb.2026.115243_b0230","doi-asserted-by":"crossref","first-page":"7891","DOI":"10.2147\/IJN.S328135","article-title":"Drug delivery of Natural Products through Nanocarriers for Effective Breast Cancer Therapy: a Comprehensive Review of Literature","volume":"16","author":"Yap","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115243_b0235","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/polym15041025","article-title":"Hyaluronic Acid-Coated Chitosan Nanoparticles as an active Targeted Carrier of Alpha Mangostin for Breast Cancer Cells","volume":"15","author":"Meylina","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.ejpb.2026.115243_b0240","article-title":"Development of propolis extract-loaded nanoparticles with chitosan and hyaluronic acid for improving solubility and stability","volume":"181","author":"Jeong","year":"2023","journal-title":"Lwt"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0245","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejpb.2026.115243_b0250","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.ijbiomac.2017.07.087","article-title":"Chitosan as a bioactive polymer: Processing, properties and applications","volume":"105","author":"Muxika","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2026.115243_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00201","article-title":"Interactions between Hyaluronan and its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer","volume":"6","author":"Misra","year":"2015","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0260","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jpba.2007.10.030","article-title":"Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound","volume":"46","author":"Baka","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115243_b0265","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijpharm.2017.11.023","article-title":"Novel cremochylomicrons for improved oral bioavailability of the antineoplastic phytomedicine berberine chloride: Optimization and pharmacokinetics","volume":"535","author":"Elsheikh","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115243_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128527","article-title":"Injectable hydrogels embedded with chitosan nanoparticles coated with hyaluronic acid for sequential release of dual drugs","volume":"256","author":"Zhang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2026.115243_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.enzmictec.2021.109889","article-title":"Hyaluronic acid-coated chitosan nanoparticles as carrier for the enzyme\/prodrug complex based on horseradish peroxidase\/indole-3-acetic acid: Characterization and potential therapeutic for bladder cancer cells","volume":"150","author":"Pereira","year":"2021","journal-title":"Enzyme Microb. Technol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0280","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41598-021-04427-w","article-title":"Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer","volume":"12","author":"Sultan","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115243_b0285","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1211\/jpp.61.03.0004","article-title":"Galactose-grafted chylomicron-mimicking emulsion: evaluation of specificity against HepG-2 and MCF-7 cell lines","volume":"61","author":"Jain","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115243_b0290","first-page":"301","article-title":"Preparation, characterization and optimization of glipizide controlled release nanoparticles","volume":"9","author":"Emami","year":"2014","journal-title":"Research in Pharmaceutical Sciences"},{"key":"10.1016\/j.ejpb.2026.115243_b0295","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.2147\/IJN.S151788","article-title":"Development of nanoemulsion for efficient brain parenteral delivery of cefuroxime: designs, characterizations, and pharmacokinetics","volume":"13","author":"Harun","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0300","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2217\/nnm-2017-0220","article-title":"Phytochylomicron as a dual nanocarrier for liver cancer targeting of luteolin: in vitro appraisal and pharmacodynamics","volume":"13","author":"Elnaggar","year":"2018","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0305","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1208\/s12249-010-9422-z","article-title":"Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin","volume":"11","author":"Jain","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115243_b0310","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.2147\/IJN.S316564","article-title":"Hyaluronic-coated albumin nanoparticles for the non-invasive delivery of apatinib in diabetic retinopathy","author":"Radwan","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2026.115243_b0315","unstructured":"Hayat, M.E., Basic techniques for transmission electron microscopy. 2012: Elsevier."},{"key":"10.1016\/j.ejpb.2026.115243_b0320","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-1-4939-8935-5_33","article-title":"Sample Preparation for Transmission Electron Microscopy","author":"Tizro","year":"2019"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115243_b0325","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/antibiotics11070950","article-title":"Grafted chitosan-hyaluronic acid (CS-g-poly (MA-co-AN) HA) complex inhibits fluconazole-resistant Candida albicans biofilm formation","volume":"11","author":"Raorane","year":"2022","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0330","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1208\/s12249-013-9960-2","article-title":"Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions","volume":"14","author":"Liu","year":"2013","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115243_b0335","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-021-02112-9","article-title":"Nanoemulsomes for Enhanced Oral Bioavailability of the Anticancer Phytochemical Andrographolide: Characterization and Pharmacokinetics","volume":"22","author":"Elsheikh","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115243_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2019.103961","article-title":"Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay","volume":"128","author":"\u00d6zt\u00fcrk","year":"2020","journal-title":"Microvasc. Res."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115243_b0345","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/nano15060435","article-title":"Synthesis, Characterization, and Stability Study of Selenium Nanoparticles Coated with Purified Polysaccharides from Ononis natrix","volume":"15","author":"Bhiri","year":"2025","journal-title":"Nanomaterials"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115243_b0350","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3390\/ma13051090","article-title":"Effect of UV and gamma irradiation sterilization processes in the properties of different polymeric nanoparticles for biomedical applications","volume":"13","author":"Tapia-Guerrero","year":"2020","journal-title":"Materials"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115243_b0355","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.3390\/molecules27113544","article-title":"Andrographolide Exhibits Anticancer activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-\u03b1 Receptor and PI3K\/AKT\/mTOR Signaling","volume":"27","author":"Tohkayomatee","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.115243_b0360","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1590\/S0100-879X2009000900013","article-title":"Synergistic antitumor effect of TRAIL and adriamycin on the human breast cancer cell line MCF-7","volume":"42","author":"Cui","year":"2009","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115243_b0365","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/pharmaceutics14061196","article-title":"siRNA Targeting Mcl-1 Potentiates the Anticancer activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells","volume":"14","author":"Pengnam","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115243_b0370","first-page":"353","article-title":"Fabrication, characterization, in vitro drug release and glucose uptake activity of 14-deoxy, 11, 12-didehydroandrographolide loaded polycaprolactone nanoparticles","volume":"12","author":"Kamaraj","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115243_b0375","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0378-5173(02)00483-0","article-title":"Biodegradable poly (\u03b5-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen","volume":"249","author":"Chawla","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0380","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1039\/C9BM01605H","article-title":"Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution","volume":"8","author":"Ji","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejpb.2026.115243_b0385","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijbiomac.2016.02.033","article-title":"Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box\u2013Behnken experimental design","volume":"87","author":"Kalam","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2026.115243_b0390","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijbiomac.2016.04.070","article-title":"Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone","volume":"89","author":"Kalam","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115243_b0395","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1021\/mp300162j","article-title":"Insight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphate","volume":"9","author":"Koukaras","year":"2012","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115243_b0400","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.progpolymsci.2006.06.001","article-title":"Chitin and chitosan: Properties and applications","volume":"31","author":"Rinaudo","year":"2006","journal-title":"Prog. Polym. Sci."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115243_b0405","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7324\/JAPS.2018.81217","article-title":"Preparation and evaluation of chitosan-tripolyphosphate nanoparticles suspension as an antibacterial agent","volume":"8","author":"Bangun","year":"2018","journal-title":"Journal of Applied Pharmaceutical Science"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0410","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/s41598-018-23064-4","article-title":"Parameters influencing the size of chitosan-TPP nano-and microparticles","volume":"8","author":"Sreekumar","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0415","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1208\/s12249-013-9943-3","article-title":"Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery","volume":"14","author":"Wang","year":"2013","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"10.1016\/j.ejpb.2026.115243_b0420","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.3390\/ijerph19127140","article-title":"Dispersion stability of 14 manufactured nanomaterials for ecotoxicity tests using Raphidocelis subcapitata","volume":"19","author":"Lee","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0425","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/molecules24010146","article-title":"Hyaluronic acid coated acid-sensitive nanoparticles for targeted therapy of adjuvant-induced arthritis in rats","volume":"24","author":"Yu","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115243_b0430","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jconrel.2013.09.032","article-title":"Hyaluronic acid-coated chitosan nanoparticles: Molecular weight-dependent effects on morphology and hyaluronic acid presentation","volume":"172","author":"Almalik","year":"2013","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0435","doi-asserted-by":"crossref","DOI":"10.1007\/s10856-022-06647-6","article-title":"Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells","volume":"33","author":"Nokhodi","year":"2022","journal-title":"J. Mater. Sci. - Mater. Med."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115243_b0440","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/chromsci\/bms146","article-title":"A green method using a micellar system for determination of andrographolide and dehydroandrographolide in human plasma","volume":"51","author":"Zhao","year":"2013","journal-title":"J. Chromatogr. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115243_b0445","doi-asserted-by":"crossref","first-page":"28","DOI":"10.46542\/pe.2024.246.2834","article-title":"Development and validation of a dissolution test for andrographolide dispersible tablets using UV-Vis spectrophotometry","volume":"24","author":"Rohana","year":"2024","journal-title":"Pharm. Educ."},{"key":"10.1016\/j.ejpb.2026.115243_b0450","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1208\/s12249-016-0512-4","article-title":"Polysaccharide encrusted multilayered nano-colloidal system of andrographolide for improved hepatoprotection","volume":"18","author":"Mishra","year":"2017","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115243_b0455","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/polym17111453","article-title":"Chitosan Nanoparticle-based Drug delivery Systems: advances, challenges, and Future Perspectives","volume":"17","author":"Stefanache","year":"2025","journal-title":"Polymers"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115243_b0460","doi-asserted-by":"crossref","first-page":"60","DOI":"10.22159\/ijap.2018v10i5.26375","article-title":"Preparation of chitosan-TPP nanoparticles: the influence of chitosan polymeric properties and formulation variables","volume":"10","author":"Al-Nemrawi","year":"2018","journal-title":"International Journal of Applied Pharmaceutics"},{"issue":"12","key":"10.1016\/j.ejpb.2026.115243_b0465","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.3390\/pharmaceutics13121993","article-title":"Nanoformulations of \u03b1-mangostin for cancer drug delivery system","volume":"13","author":"Meylina","year":"2021","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115243_b0470","doi-asserted-by":"crossref","first-page":"793","DOI":"10.12991\/mpj.2017.21","article-title":"In vitro gene silencing effect of chitosan\/shRNA PDGF-D nanoparticles in breast cancer","volume":"21","author":"Ekentok","year":"2017","journal-title":"Marmara Pharmaceutical Journal"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115243_b0475","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/jpm11060571","article-title":"Recent advances in tumor targeting via EPR effect for cancer treatment","volume":"11","author":"Subhan","year":"2021","journal-title":"Journal of Personalized Medicine"},{"key":"10.1016\/j.ejpb.2026.115243_b0480","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1073004","article-title":"Green synthesis of hyaluronic acid coated, thiolated chitosan nanoparticles for CD44 targeted delivery and sustained release of Cisplatin in cervical carcinoma","volume":"13","author":"Kousar","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115243_b0485","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","article-title":"Dynamic light scattering: a practical guide and applications in biomedical sciences","volume":"8","author":"Stetefeld","year":"2016","journal-title":"Biophys. Rev."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115243_b0490","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3109\/10717544.2010.509357","article-title":"Hyaluronic acid\/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB","volume":"17","author":"Paraj\u00f3","year":"2010","journal-title":"Drug Deliv."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115243_b0495","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2017.03.008","article-title":"Surface functionalization of methotrexate-loaded chitosan nanoparticles with hyaluronic acid\/human serum albumin: Comparative characterization and in vitro cytotoxicity","volume":"522","author":"Hashad","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115243_b0500","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11051-020-04838-2","article-title":"Targeted delivery of a short antimicrobial peptide against CD44-overexpressing tumor cells using hyaluronic acid-coated chitosan nanoparticles: an in vitro study","volume":"22","author":"Taghipour-Sabzevar","year":"2020","journal-title":"J. Nanopart. Res."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115243_b0505","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/pat.5230","article-title":"pH\u2010sensitive polymers: Classification and some fine potential applications","volume":"32","author":"Ofridam","year":"2021","journal-title":"Polym. Adv. Technol."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115243_b0510","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3390\/mi13101623","article-title":"Sustained drug release from smart nanoparticles in cancer therapy: a comprehensive review","volume":"13","author":"Bai","year":"2022","journal-title":"Micromachines"},{"key":"10.1016\/j.ejpb.2026.115243_b0515","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.colsurfb.2014.01.017","article-title":"Hyaluronated nanoparticles with pH-and enzyme-responsive drug release properties","volume":"116","author":"Kim","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115243_b0520","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijpharm.2014.09.016","article-title":"Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro\u2013in vivo correlation","volume":"475","author":"Jiang","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0525","doi-asserted-by":"crossref","first-page":"28856","DOI":"10.1038\/s41598-025-13652-6","article-title":"Degradation kinetics of Andrographolide in aqueous solution, product identification and biological activity evaluation","volume":"15","author":"Jaidee","year":"2025","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115243_b0530","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1021\/bm400451v","article-title":"Chitosan-based nanocarriers with pH and light dual response for anticancer drug delivery","volume":"14","author":"Meng","year":"2013","journal-title":"Biomacromolecules"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115243_b0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264825","article-title":"Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly (lactic-co-glycolic acid)","volume":"17","author":"Heredia","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0540","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3304105","article-title":"Hyaluronic Acid\u2010Coated Chitosan\/Gelatin Nanoparticles as a New Strategy for Topical delivery of Metformin in Melanoma","volume":"2023","author":"Ebrahimnejad","year":"2023","journal-title":"Biomed Res. Int."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115243_b0545","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3390\/pharmaceutics15051364","article-title":"Controlled drug release from nanoengineered polysaccharides","volume":"15","author":"Bayer","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115243_b0550","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.1021\/acsomega.8b03562","article-title":"A protocol to characterize peptide-based drug delivery systems for miRNAs","volume":"4","author":"Schachner-Nedherer","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejpb.2026.115243_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113491","article-title":"Lipid nanoparticles containing coenzyme Q10 for topical applications: an overview of their characterization","volume":"230","author":"Souza","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"9","key":"10.1016\/j.ejpb.2026.115243_b0560","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3390\/pharmaceutics14091798","article-title":"Quality by design-driven zeta potential optimisation study of liposomes with charge imparting membrane additives","volume":"14","author":"N\u00e9meth","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115243_b0565","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.580118","article-title":"Lipid nanoparticles as carriers for bioactive delivery","volume":"9","author":"Dhiman","year":"2021","journal-title":"Front. Chem."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0570","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/pharmaceutics15020503","article-title":"Chitosan-based nanoparticles with optimized parameters for targeted delivery of a specific anticancer drug\u2014a comprehensive review","volume":"15","author":"Kurczewska","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115243_b0575","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/pharmaceutics16050688","article-title":"Polymer Matrix and Manufacturing Methods in Solid Dispersion System for Enhancing Andrographolide Solubility and Absorption: a Systematic Review","volume":"16","author":"Tipduangta","year":"2024","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115243_b0580","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/pharmaceutics15030879","article-title":"Chitosan-based nano-smart drug delivery system in breast cancer therapy","volume":"15","author":"Herdiana","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115243_b0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-016-0245-2","article-title":"Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44","volume":"15","author":"Wang","year":"2017","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0590","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1515\/biol-2019-0052","article-title":"Andrographolide as a therapeutic agent against breast and ovarian cancers","volume":"14","author":"Beesetti","year":"2019","journal-title":"Open Life Sci."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115243_b0595","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.3390\/ijms21072506","article-title":"Oral bioavailability enhancement and anti-fatigue assessment of the andrographolide loaded solid dispersion","volume":"21","author":"Yen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115243_b0600","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/md21040211","article-title":"Chitosan nanoparticles-based cancer drug delivery: application and challenges","volume":"21","author":"Sachdeva","year":"2023","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejpb.2026.115243_b0605","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.990145","article-title":"Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: recent advances","volume":"10","author":"Jia","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115243_b0610","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/pharmaceutics11070301","article-title":"Hyaluronic acid-coated nanomedicine for targeted cancer therapy","volume":"11","author":"Kim","year":"2019","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.ejpb.2026.115243_b0615","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2174\/156652412802480826","article-title":"Andrographolide inhibits osteopontin expression and breast tumor growth through down regulation of PI3 kinase\/Akt signaling pathway","volume":"12","author":"Kumar","year":"2012","journal-title":"Curr. Mol. Med."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115243_b0620","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4314\/ajtcam.v4i3.31228","article-title":"Apoptosis Inducing effect of Andrographolide on TF-47 Human Breast Cancer Cell Line","volume":"4","author":"Harjotaruno","year":"2008","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"key":"10.1016\/j.ejpb.2026.115243_b0625","unstructured":"!!! INVALID CITATION !!! (54)."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115243_b0630","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/08982104.2024.2348643","article-title":"Hyaluronic acid-coated liposomes for enhanced in vivo efficacy of neogambogic acid via active tumor cell targeting and prolonged systemic exposure","volume":"34","author":"Lv","year":"2024","journal-title":"J. Liposome Res."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115243_b0635","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3390\/plants12101969","article-title":"Anti-Cancer Agent: the Labdane Diterpenoid-Andrographolide","volume":"12","author":"Tundis","year":"2023","journal-title":"Plants"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0640","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.nano.2015.09.014","article-title":"Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy","volume":"12","author":"Wang","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115243_b0645","article-title":"Bax\/Bcl-2 Ratio as the Golden Marker of Apoptosis: Molecular Mechanisms and Regulatory Pathways. International Journal of Cell and Biomedical","volume":"4","author":"Thias","year":"2025","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.ejpb.2026.115243_b0650","doi-asserted-by":"crossref","first-page":"26142","DOI":"10.18632\/oncotarget.15393","article-title":"Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells","volume":"8","author":"Banerjee","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.ejpb.2026.115243_b0655","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3109\/03639045.2013.810636","article-title":"Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies","volume":"40","author":"Parveen","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2026.115243_b0660","doi-asserted-by":"crossref","DOI":"10.1177\/09603271251322531","article-title":"Enhancing breast cancer treatment: evaluating the efficacy of hyaluronic acid-coated tamoxifen-loaded solid lipid nanoparticles on MCF7 cells","volume":"44","author":"Ghayoumipour","year":"2025","journal-title":"Hum. Exp. Toxicol."},{"issue":"15","key":"10.1016\/j.ejpb.2026.115243_b0665","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2174\/138920112804724855","article-title":"Nanoparticle engineering enhances anticancer efficacy of andrographolide in MCF-7 cells and mice bearing EAC","volume":"13","author":"Roy","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.115243_b0670","article-title":"Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer","volume":"16","author":"Mansoori-Kermani","year":"2022","journal-title":"Mater. Today Bio"},{"issue":"45","key":"10.1016\/j.ejpb.2026.115243_b0675","doi-asserted-by":"crossref","first-page":"38624","DOI":"10.1039\/C6RA03997A","article-title":"Hyaluronic acid-coated poly (\u03b2-amino) ester nanoparticles as carrier of doxorubicin for overcoming drug resistance in breast cancer cells","volume":"6","author":"An","year":"2016","journal-title":"RSC Adv."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115243_b0680","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.nano.2017.10.010","article-title":"CD44 targeting hyaluronic acid coated lapatinib nanocrystals foster the efficacy against triple-negative breast cancer","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0685","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-016-0257-0","article-title":"Cytotoxicity and cell cycle arrest induced by andrographolide lead to programmed cell death of MDA-MB-231 breast cancer cell line","volume":"23","author":"Banerjee","year":"2016","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115243_b0690","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejpb.2026.115243_b0695","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-385493-3.00004-8","article-title":"Apoptosis and beyond: cytometry in studies of programmed cell death","volume":"103","author":"Wlodkowic","year":"2011","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.ejpb.2026.115243_b0700","article-title":"Flow cytometric analysis of apoptotic biomarkers in actinomycin D-treated SiHa cervical cancer cells","volume":"174","author":"Punchoo","year":"2021","journal-title":"Journal of Visualized Experiments (JoVE)"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115243_b0705","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/21691401.2019.1577876","article-title":"Chitosan nanoparticles induced the antitumor effect in hepatocellular carcinoma cells by regulating ROS-mediated mitochondrial damage and endoplasmic reticulum stress","volume":"47","author":"Jiang","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115243_b0710","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.3390\/ijms19082310","article-title":"Hyaluronic acid-decorated chitosan nanoparticles for CD44-targeted delivery of everolimus","volume":"19","author":"Chiesa","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115243_b0715","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.2147\/IJN.S113469","article-title":"GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy","author":"Hu","year":"2016","journal-title":"Int. J. Nanomed."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112600264X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112600264X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:48:10Z","timestamp":1791024490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112600264X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":143,"alternative-id":["S093964112600264X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115243","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-responsive hyalo-chitosan nanoparticles for targeted delivery of andrographolide in CD44+ breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115243"}}